Skip to main content
Premium Trial:

Request an Annual Quote

GLS, Michigan High Throughput Screening Center to Offer Cellular Screening Services

NEW YORK (GenomeWeb News) - Global Lifescience Solutions, a segment of non-profit safety testing firm NSF International, said this week that it will partner with the Michigan High Throughput Screening Center in Kalamazoo, Mich., to offer screening services that may help companies identify potential leads for drug discovery.
Through the partnership, MHTSC will add high-content screening services from GLS to its current menu of high-throughput screening services.
MHTSC, a non-profit located at Kalamazoo Valley Community College, will now provide prescreening services, assay development, development and optimization services, follow-up screening services, and will help companies examine multiple cellular targets and parameters in individually imaged cells. MHTSC does not charge licensing or royalty fees.
"As more and more drug companies outsource their research and testing, our goal is to provide solutions that will expedite the drug development process," said Aline Lindbeck, general manager of the Ann Arbor-based GLS.
GLS said it expects MHTSC to offer pre-screening services to biotechnology companies, government institutions, and to pharmaceutical companies that do not have in-house screening available.
Financial terms of the agreement were not released.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.